TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $908,000 | +197.7% | 12,068 | +6.1% | 0.01% | +350.0% |
| Q1 2022 | $305,000 | -43.4% | 11,369 | +0.6% | 0.00% | -50.0% |
| Q4 2021 | $539,000 | -28.7% | 11,303 | -0.7% | 0.00% | -33.3% |
| Q3 2021 | $756,000 | -12.9% | 11,381 | +2.3% | 0.01% | -14.3% |
| Q2 2021 | $868,000 | -23.0% | 11,130 | -6.6% | 0.01% | -30.0% |
| Q1 2021 | $1,128,000 | -19.7% | 11,920 | +3.4% | 0.01% | -23.1% |
| Q4 2020 | $1,405,000 | +58.0% | 11,528 | +13.3% | 0.01% | +44.4% |
| Q3 2020 | $889,000 | +84.8% | 10,175 | +36.6% | 0.01% | +28.6% |
| Q2 2020 | $481,000 | – | 7,451 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |